A modeling and simulation framework to support early clinical drug development decisions in oncology
J Clin Pharmacol
.
2011 Jan;51(1):6-8.
doi: 10.1177/0091270010376970.
Epub 2010 Jul 13.
Authors
Rene Bruno
1
,
Jian-Feng Lu
,
Yu-Nien Sun
,
Laurent Claret
Affiliation
1
Strategic Consulting Services, Pharsight-A Certara Company, Mountain View, California, USA. rbruno@pharsight.com
PMID:
20628172
DOI:
10.1177/0091270010376970
No abstract available
MeSH terms
Antineoplastic Agents / pharmacology
Computer Simulation*
Drug Design*
Humans
Models, Biological*
Neoplasms / drug therapy
Neoplasms / pathology
Survival Analysis
Substances
Antineoplastic Agents